カテゴリ： 世界, 医療/バイオ, Market Monitor Global

オピオイド誘発性便秘（OLC）用治療薬のグローバル市場展望 2023年-2029年：市販薬、処方薬

■ 英語タイトル：Opioid Induced Constipation (OlC) Drugs Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC16504）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC16504
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：77
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[オピオイド誘発性便秘（OLC）用治療薬のグローバル市場展望 2023年-2029年：市販薬、処方薬]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のオピオイド誘発性便秘（OLC）用治療薬市場規模と予測を収録しています。・世界のオピオイド誘発性便秘（OLC）用治療薬市場：売上、2018年-2023年、2024年-2029年
・世界のオピオイド誘発性便秘（OLC）用治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のオピオイド誘発性便秘（OLC）用治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「市販薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

オピオイド誘発性便秘（OLC）用治療薬のグローバル主要企業は、Dr. Reddy's Laboratories Ltd.、 Bausch Health Companies Inc、 Pharmaceutical lndustries Ltd.、 Novartis AG、 Takeda Pharmaceutical Company Limited、 Shionogi & Co., Ltd.、 Mallinckrodt Plc、 Merck & Co, Inc.、 Astra Zeneca Plc、 Cosmo Pharmaceuticals、 Tevaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、オピオイド誘発性便秘（OLC）用治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のオピオイド誘発性便秘（OLC）用治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のオピオイド誘発性便秘（OLC）用治療薬市場：タイプ別市場シェア、2022年
・市販薬、処方薬

世界のオピオイド誘発性便秘（OLC）用治療薬市場：用途別、2018年-2023年、2024年-2029年
世界のオピオイド誘発性便秘（OLC）用治療薬市場：用途別市場シェア、2022年
・クリニック、病院、その他

世界のオピオイド誘発性便秘（OLC）用治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のオピオイド誘発性便秘（OLC）用治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるオピオイド誘発性便秘（OLC）用治療薬のグローバル売上、2018年-2023年
・主要企業におけるオピオイド誘発性便秘（OLC）用治療薬のグローバル売上シェア、2022年
・主要企業におけるオピオイド誘発性便秘（OLC）用治療薬のグローバル販売量、2018年-2023年
・主要企業におけるオピオイド誘発性便秘（OLC）用治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Dr. Reddy's Laboratories Ltd.、 Bausch Health Companies Inc、 Pharmaceutical lndustries Ltd.、 Novartis AG、 Takeda Pharmaceutical Company Limited、 Shionogi & Co., Ltd.、 Mallinckrodt Plc、 Merck & Co, Inc.、 Astra Zeneca Plc、 Cosmo Pharmaceuticals、 Teva

*************************************************************

・調査・分析レポートの概要
オピオイド誘発性便秘（OLC）用治療薬市場の定義
市場セグメント
世界のオピオイド誘発性便秘（OLC）用治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のオピオイド誘発性便秘（OLC）用治療薬市場規模
世界のオピオイド誘発性便秘（OLC）用治療薬市場規模：2022年 VS 2029年
世界のオピオイド誘発性便秘（OLC）用治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのオピオイド誘発性便秘（OLC）用治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のオピオイド誘発性便秘（OLC）用治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：市販薬、処方薬
オピオイド誘発性便秘（OLC）用治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：クリニック、病院、その他
オピオイド誘発性便秘（OLC）用治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別オピオイド誘発性便秘（OLC）用治療薬市場規模 2022年と2029年
地域別オピオイド誘発性便秘（OLC）用治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Dr. Reddy's Laboratories Ltd.、 Bausch Health Companies Inc、 Pharmaceutical lndustries Ltd.、 Novartis AG、 Takeda Pharmaceutical Company Limited、 Shionogi & Co., Ltd.、 Mallinckrodt Plc、 Merck & Co, Inc.、 Astra Zeneca Plc、 Cosmo Pharmaceuticals、 Teva
...

This research report provides a comprehensive analysis of the Opioid Induced Constipation (OlC) Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Opioid Induced Constipation (OlC) Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Opioid Induced Constipation (OlC) Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Opioid Induced Constipation (OlC) Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Opioid Induced Constipation (OlC) Drugs market presents opportunities for various stakeholders, including Clinic, Hospital. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Opioid Induced Constipation (OlC) Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Opioid Induced Constipation (OlC) Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Opioid Induced Constipation (OlC) Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Opioid Induced Constipation (OlC) Drugs market.
Market Overview: The report provides a comprehensive overview of the Opioid Induced Constipation (OlC) Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Over the Counter Drugs, Prescribed Drugs), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Opioid Induced Constipation (OlC) Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Opioid Induced Constipation (OlC) Drugs market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Opioid Induced Constipation (OlC) Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Opioid Induced Constipation (OlC) Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Opioid Induced Constipation (OlC) Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Opioid Induced Constipation (OlC) Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Opioid Induced Constipation (OlC) Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Opioid Induced Constipation (OlC) Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Opioid Induced Constipation (OlC) Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Over the Counter Drugs
Prescribed Drugs
Market segment by Application
Clinic
Hospital
Others
Global Opioid Induced Constipation (OlC) Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Dr. Reddy’s Laboratories Ltd.
Bausch Health Companies Inc
Pharmaceutical lndustries Ltd.
Novartis AG
Takeda Pharmaceutical Company Limited
Shionogi & Co., Ltd.
Mallinckrodt Plc
Merck & Co, Inc.
Astra Zeneca Plc
Cosmo Pharmaceuticals
Teva
Outline of Major Chapters:
Chapter 1: Introduces the definition of Opioid Induced Constipation (OlC) Drugs, market overview.
Chapter 2: Global Opioid Induced Constipation (OlC) Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Opioid Induced Constipation (OlC) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Opioid Induced Constipation (OlC) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Opioid Induced Constipation (OlC) Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Opioid Induced Constipation (OlC) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Opioid Induced Constipation (OlC) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Opioid Induced Constipation (OlC) Drugs Overall Market Size
2.1 Global Opioid Induced Constipation (OlC) Drugs Market Size: 2022 VS 2029
2.2 Global Opioid Induced Constipation (OlC) Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Opioid Induced Constipation (OlC) Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Opioid Induced Constipation (OlC) Drugs Players in Global Market
3.2 Top Global Opioid Induced Constipation (OlC) Drugs Companies Ranked by Revenue
3.3 Global Opioid Induced Constipation (OlC) Drugs Revenue by Companies
3.4 Global Opioid Induced Constipation (OlC) Drugs Sales by Companies
3.5 Global Opioid Induced Constipation (OlC) Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Opioid Induced Constipation (OlC) Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Opioid Induced Constipation (OlC) Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Opioid Induced Constipation (OlC) Drugs Players in Global Market
3.8.1 List of Global Tier 1 Opioid Induced Constipation (OlC) Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Opioid Induced Constipation (OlC) Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Opioid Induced Constipation (OlC) Drugs Market Size Markets, 2022 & 2029
4.1.2 Over the Counter Drugs
4.1.3 Prescribed Drugs
4.2 By Type – Global Opioid Induced Constipation (OlC) Drugs Revenue & Forecasts
4.2.1 By Type – Global Opioid Induced Constipation (OlC) Drugs Revenue, 2018-2023
4.2.2 By Type – Global Opioid Induced Constipation (OlC) Drugs Revenue, 2024-2029
4.2.3 By Type – Global Opioid Induced Constipation (OlC) Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Opioid Induced Constipation (OlC) Drugs Sales & Forecasts
4.3.1 By Type – Global Opioid Induced Constipation (OlC) Drugs Sales, 2018-2023
4.3.2 By Type – Global Opioid Induced Constipation (OlC) Drugs Sales, 2024-2029
4.3.3 By Type – Global Opioid Induced Constipation (OlC) Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Opioid Induced Constipation (OlC) Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Opioid Induced Constipation (OlC) Drugs Market Size, 2022 & 2029
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application – Global Opioid Induced Constipation (OlC) Drugs Revenue & Forecasts
5.2.1 By Application – Global Opioid Induced Constipation (OlC) Drugs Revenue, 2018-2023
5.2.2 By Application – Global Opioid Induced Constipation (OlC) Drugs Revenue, 2024-2029
5.2.3 By Application – Global Opioid Induced Constipation (OlC) Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Opioid Induced Constipation (OlC) Drugs Sales & Forecasts
5.3.1 By Application – Global Opioid Induced Constipation (OlC) Drugs Sales, 2018-2023
5.3.2 By Application – Global Opioid Induced Constipation (OlC) Drugs Sales, 2024-2029
5.3.3 By Application – Global Opioid Induced Constipation (OlC) Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Opioid Induced Constipation (OlC) Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Opioid Induced Constipation (OlC) Drugs Market Size, 2022 & 2029
6.2 By Region – Global Opioid Induced Constipation (OlC) Drugs Revenue & Forecasts
6.2.1 By Region – Global Opioid Induced Constipation (OlC) Drugs Revenue, 2018-2023
6.2.2 By Region – Global Opioid Induced Constipation (OlC) Drugs Revenue, 2024-2029
6.2.3 By Region – Global Opioid Induced Constipation (OlC) Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Opioid Induced Constipation (OlC) Drugs Sales & Forecasts
6.3.1 By Region – Global Opioid Induced Constipation (OlC) Drugs Sales, 2018-2023
6.3.2 By Region – Global Opioid Induced Constipation (OlC) Drugs Sales, 2024-2029
6.3.3 By Region – Global Opioid Induced Constipation (OlC) Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Opioid Induced Constipation (OlC) Drugs Revenue, 2018-2029
6.4.2 By Country – North America Opioid Induced Constipation (OlC) Drugs Sales, 2018-2029
6.4.3 US Opioid Induced Constipation (OlC) Drugs Market Size, 2018-2029
6.4.4 Canada Opioid Induced Constipation (OlC) Drugs Market Size, 2018-2029
6.4.5 Mexico Opioid Induced Constipation (OlC) Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Opioid Induced Constipation (OlC) Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Opioid Induced Constipation (OlC) Drugs Sales, 2018-2029
6.5.3 Germany Opioid Induced Constipation (OlC) Drugs Market Size, 2018-2029
6.5.4 France Opioid Induced Constipation (OlC) Drugs Market Size, 2018-2029
6.5.5 U.K. Opioid Induced Constipation (OlC) Drugs Market Size, 2018-2029
6.5.6 Italy Opioid Induced Constipation (OlC) Drugs Market Size, 2018-2029
6.5.7 Russia Opioid Induced Constipation (OlC) Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Opioid Induced Constipation (OlC) Drugs Market Size, 2018-2029
6.5.9 Benelux Opioid Induced Constipation (OlC) Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Opioid Induced Constipation (OlC) Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Opioid Induced Constipation (OlC) Drugs Sales, 2018-2029
6.6.3 China Opioid Induced Constipation (OlC) Drugs Market Size, 2018-2029
6.6.4 Japan Opioid Induced Constipation (OlC) Drugs Market Size, 2018-2029
6.6.5 South Korea Opioid Induced Constipation (OlC) Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Opioid Induced Constipation (OlC) Drugs Market Size, 2018-2029
6.6.7 India Opioid Induced Constipation (OlC) Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Opioid Induced Constipation (OlC) Drugs Revenue, 2018-2029
6.7.2 By Country – South America Opioid Induced Constipation (OlC) Drugs Sales, 2018-2029
6.7.3 Brazil Opioid Induced Constipation (OlC) Drugs Market Size, 2018-2029
6.7.4 Argentina Opioid Induced Constipation (OlC) Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Opioid Induced Constipation (OlC) Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Opioid Induced Constipation (OlC) Drugs Sales, 2018-2029
6.8.3 Turkey Opioid Induced Constipation (OlC) Drugs Market Size, 2018-2029
6.8.4 Israel Opioid Induced Constipation (OlC) Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Opioid Induced Constipation (OlC) Drugs Market Size, 2018-2029
6.8.6 UAE Opioid Induced Constipation (OlC) Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Dr. Reddy’s Laboratories Ltd.
7.1.1 Dr. Reddy’s Laboratories Ltd. Company Summary
7.1.2 Dr. Reddy’s Laboratories Ltd. Business Overview
7.1.3 Dr. Reddy’s Laboratories Ltd. Opioid Induced Constipation (OlC) Drugs Major Product Offerings
7.1.4 Dr. Reddy’s Laboratories Ltd. Opioid Induced Constipation (OlC) Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Dr. Reddy’s Laboratories Ltd. Key News & Latest Developments
7.2 Bausch Health Companies Inc
7.2.1 Bausch Health Companies Inc Company Summary
7.2.2 Bausch Health Companies Inc Business Overview
7.2.3 Bausch Health Companies Inc Opioid Induced Constipation (OlC) Drugs Major Product Offerings
7.2.4 Bausch Health Companies Inc Opioid Induced Constipation (OlC) Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Bausch Health Companies Inc Key News & Latest Developments
7.3 Pharmaceutical lndustries Ltd.
7.3.1 Pharmaceutical lndustries Ltd. Company Summary
7.3.2 Pharmaceutical lndustries Ltd. Business Overview
7.3.3 Pharmaceutical lndustries Ltd. Opioid Induced Constipation (OlC) Drugs Major Product Offerings
7.3.4 Pharmaceutical lndustries Ltd. Opioid Induced Constipation (OlC) Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Pharmaceutical lndustries Ltd. Key News & Latest Developments
7.4 Novartis AG
7.4.1 Novartis AG Company Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Opioid Induced Constipation (OlC) Drugs Major Product Offerings
7.4.4 Novartis AG Opioid Induced Constipation (OlC) Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Novartis AG Key News & Latest Developments
7.5 Takeda Pharmaceutical Company Limited
7.5.1 Takeda Pharmaceutical Company Limited Company Summary
7.5.2 Takeda Pharmaceutical Company Limited Business Overview
7.5.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OlC) Drugs Major Product Offerings
7.5.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OlC) Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Takeda Pharmaceutical Company Limited Key News & Latest Developments
7.6 Shionogi & Co., Ltd.
7.6.1 Shionogi & Co., Ltd. Company Summary
7.6.2 Shionogi & Co., Ltd. Business Overview
7.6.3 Shionogi & Co., Ltd. Opioid Induced Constipation (OlC) Drugs Major Product Offerings
7.6.4 Shionogi & Co., Ltd. Opioid Induced Constipation (OlC) Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Shionogi & Co., Ltd. Key News & Latest Developments
7.7 Mallinckrodt Plc
7.7.1 Mallinckrodt Plc Company Summary
7.7.2 Mallinckrodt Plc Business Overview
7.7.3 Mallinckrodt Plc Opioid Induced Constipation (OlC) Drugs Major Product Offerings
7.7.4 Mallinckrodt Plc Opioid Induced Constipation (OlC) Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Mallinckrodt Plc Key News & Latest Developments
7.8 Merck & Co, Inc.
7.8.1 Merck & Co, Inc. Company Summary
7.8.2 Merck & Co, Inc. Business Overview
7.8.3 Merck & Co, Inc. Opioid Induced Constipation (OlC) Drugs Major Product Offerings
7.8.4 Merck & Co, Inc. Opioid Induced Constipation (OlC) Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Merck & Co, Inc. Key News & Latest Developments
7.9 Astra Zeneca Plc
7.9.1 Astra Zeneca Plc Company Summary
7.9.2 Astra Zeneca Plc Business Overview
7.9.3 Astra Zeneca Plc Opioid Induced Constipation (OlC) Drugs Major Product Offerings
7.9.4 Astra Zeneca Plc Opioid Induced Constipation (OlC) Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Astra Zeneca Plc Key News & Latest Developments
7.10 Cosmo Pharmaceuticals
7.10.1 Cosmo Pharmaceuticals Company Summary
7.10.2 Cosmo Pharmaceuticals Business Overview
7.10.3 Cosmo Pharmaceuticals Opioid Induced Constipation (OlC) Drugs Major Product Offerings
7.10.4 Cosmo Pharmaceuticals Opioid Induced Constipation (OlC) Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Cosmo Pharmaceuticals Key News & Latest Developments
7.11 Teva
7.11.1 Teva Company Summary
7.11.2 Teva Business Overview
7.11.3 Teva Opioid Induced Constipation (OlC) Drugs Major Product Offerings
7.11.4 Teva Opioid Induced Constipation (OlC) Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Teva Key News & Latest Developments
8 Global Opioid Induced Constipation (OlC) Drugs Production Capacity, Analysis
8.1 Global Opioid Induced Constipation (OlC) Drugs Production Capacity, 2018-2029
8.2 Opioid Induced Constipation (OlC) Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Opioid Induced Constipation (OlC) Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Opioid Induced Constipation (OlC) Drugs Supply Chain Analysis
10.1 Opioid Induced Constipation (OlC) Drugs Industry Value Chain
10.2 Opioid Induced Constipation (OlC) Drugs Upstream Market
10.3 Opioid Induced Constipation (OlC) Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Opioid Induced Constipation (OlC) Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Opioid Induced Constipation (OlC) Drugs in Global Market
Table 2. Top Opioid Induced Constipation (OlC) Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Opioid Induced Constipation (OlC) Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Opioid Induced Constipation (OlC) Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Opioid Induced Constipation (OlC) Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Opioid Induced Constipation (OlC) Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Opioid Induced Constipation (OlC) Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Opioid Induced Constipation (OlC) Drugs Product Type
Table 9. List of Global Tier 1 Opioid Induced Constipation (OlC) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Opioid Induced Constipation (OlC) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Opioid Induced Constipation (OlC) Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Opioid Induced Constipation (OlC) Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Opioid Induced Constipation (OlC) Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Opioid Induced Constipation (OlC) Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Opioid Induced Constipation (OlC) Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Opioid Induced Constipation (OlC) Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Opioid Induced Constipation (OlC) Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Opioid Induced Constipation (OlC) Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Opioid Induced Constipation (OlC) Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Opioid Induced Constipation (OlC) Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Opioid Induced Constipation (OlC) Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Opioid Induced Constipation (OlC) Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Opioid Induced Constipation (OlC) Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Opioid Induced Constipation (OlC) Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Opioid Induced Constipation (OlC) Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Opioid Induced Constipation (OlC) Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Opioid Induced Constipation (OlC) Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Opioid Induced Constipation (OlC) Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Opioid Induced Constipation (OlC) Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Opioid Induced Constipation (OlC) Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Opioid Induced Constipation (OlC) Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Opioid Induced Constipation (OlC) Drugs Sales, (K Units), 2024-2029
Table 46. Dr. Reddy's Laboratories Ltd. Company Summary
Table 47. Dr. Reddy's Laboratories Ltd. Opioid Induced Constipation (OlC) Drugs Product Offerings
Table 48. Dr. Reddy's Laboratories Ltd. Opioid Induced Constipation (OlC) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Dr. Reddy's Laboratories Ltd. Key News & Latest Developments
Table 50. Bausch Health Companies Inc Company Summary
Table 51. Bausch Health Companies Inc Opioid Induced Constipation (OlC) Drugs Product Offerings
Table 52. Bausch Health Companies Inc Opioid Induced Constipation (OlC) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Bausch Health Companies Inc Key News & Latest Developments
Table 54. Pharmaceutical lndustries Ltd. Company Summary
Table 55. Pharmaceutical lndustries Ltd. Opioid Induced Constipation (OlC) Drugs Product Offerings
Table 56. Pharmaceutical lndustries Ltd. Opioid Induced Constipation (OlC) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Pharmaceutical lndustries Ltd. Key News & Latest Developments
Table 58. Novartis AG Company Summary
Table 59. Novartis AG Opioid Induced Constipation (OlC) Drugs Product Offerings
Table 60. Novartis AG Opioid Induced Constipation (OlC) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Novartis AG Key News & Latest Developments
Table 62. Takeda Pharmaceutical Company Limited Company Summary
Table 63. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OlC) Drugs Product Offerings
Table 64. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OlC) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Takeda Pharmaceutical Company Limited Key News & Latest Developments
Table 66. Shionogi & Co., Ltd. Company Summary
Table 67. Shionogi & Co., Ltd. Opioid Induced Constipation (OlC) Drugs Product Offerings
Table 68. Shionogi & Co., Ltd. Opioid Induced Constipation (OlC) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Shionogi & Co., Ltd. Key News & Latest Developments
Table 70. Mallinckrodt Plc Company Summary
Table 71. Mallinckrodt Plc Opioid Induced Constipation (OlC) Drugs Product Offerings
Table 72. Mallinckrodt Plc Opioid Induced Constipation (OlC) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Mallinckrodt Plc Key News & Latest Developments
Table 74. Merck & Co, Inc. Company Summary
Table 75. Merck & Co, Inc. Opioid Induced Constipation (OlC) Drugs Product Offerings
Table 76. Merck & Co, Inc. Opioid Induced Constipation (OlC) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Merck & Co, Inc. Key News & Latest Developments
Table 78. Astra Zeneca Plc Company Summary
Table 79. Astra Zeneca Plc Opioid Induced Constipation (OlC) Drugs Product Offerings
Table 80. Astra Zeneca Plc Opioid Induced Constipation (OlC) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Astra Zeneca Plc Key News & Latest Developments
Table 82. Cosmo Pharmaceuticals Company Summary
Table 83. Cosmo Pharmaceuticals Opioid Induced Constipation (OlC) Drugs Product Offerings
Table 84. Cosmo Pharmaceuticals Opioid Induced Constipation (OlC) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Cosmo Pharmaceuticals Key News & Latest Developments
Table 86. Teva Company Summary
Table 87. Teva Opioid Induced Constipation (OlC) Drugs Product Offerings
Table 88. Teva Opioid Induced Constipation (OlC) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Teva Key News & Latest Developments
Table 90. Opioid Induced Constipation (OlC) Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 91. Global Opioid Induced Constipation (OlC) Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Opioid Induced Constipation (OlC) Drugs Production by Region, 2018-2023 (K Units)
Table 93. Global Opioid Induced Constipation (OlC) Drugs Production by Region, 2024-2029 (K Units)
Table 94. Opioid Induced Constipation (OlC) Drugs Market Opportunities & Trends in Global Market
Table 95. Opioid Induced Constipation (OlC) Drugs Market Drivers in Global Market
Table 96. Opioid Induced Constipation (OlC) Drugs Market Restraints in Global Market
Table 97. Opioid Induced Constipation (OlC) Drugs Raw Materials
Table 98. Opioid Induced Constipation (OlC) Drugs Raw Materials Suppliers in Global Market
Table 99. Typical Opioid Induced Constipation (OlC) Drugs Downstream
Table 100. Opioid Induced Constipation (OlC) Drugs Downstream Clients in Global Market
Table 101. Opioid Induced Constipation (OlC) Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Opioid Induced Constipation (OlC) Drugs Segment by Type in 2022
Figure 2. Opioid Induced Constipation (OlC) Drugs Segment by Application in 2022
Figure 3. Global Opioid Induced Constipation (OlC) Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Opioid Induced Constipation (OlC) Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Opioid Induced Constipation (OlC) Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Opioid Induced Constipation (OlC) Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Opioid Induced Constipation (OlC) Drugs Revenue in 2022
Figure 9. By Type - Global Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Opioid Induced Constipation (OlC) Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Opioid Induced Constipation (OlC) Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Opioid Induced Constipation (OlC) Drugs Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Opioid Induced Constipation (OlC) Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Opioid Induced Constipation (OlC) Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Opioid Induced Constipation (OlC) Drugs Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Opioid Induced Constipation (OlC) Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Opioid Induced Constipation (OlC) Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Opioid Induced Constipation (OlC) Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Opioid Induced Constipation (OlC) Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Opioid Induced Constipation (OlC) Drugs Sales Market Share, 2018-2029
Figure 23. US Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Opioid Induced Constipation (OlC) Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Opioid Induced Constipation (OlC) Drugs Sales Market Share, 2018-2029
Figure 28. Germany Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Opioid Induced Constipation (OlC) Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Opioid Induced Constipation (OlC) Drugs Sales Market Share, 2018-2029
Figure 37. China Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Opioid Induced Constipation (OlC) Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Opioid Induced Constipation (OlC) Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Opioid Induced Constipation (OlC) Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Opioid Induced Constipation (OlC) Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Opioid Induced Constipation (OlC) Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Opioid Induced Constipation (OlC) Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Opioid Induced Constipation (OlC) Drugs by Region, 2022 VS 2029
Figure 54. Opioid Induced Constipation (OlC) Drugs Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 便秘用栄養補助食品のグローバル市場展望 2023年-2029年：繊維・特殊炭水化物、ビタミン、ミネラル、カロテノイド、オメガ-3脂肪酸、プレバイオティクス・プロバイオティクス、アミノ酸・タンパク質、その他
  • 電子ビーム誘導電流技術のグローバル市場展望 2023年-2029年：従来型電子ビーム誘導電流技術、走査型透過電子顕微鏡（STEM）電子ビーム誘導電流技術
  • イボシデニブ薬のグローバル市場展望 2023年-2029年：60錠、30錠
  • ソマバート薬のグローバル市場展望 2023年-2029年：プレフィルド、ノンプレフィルド
  • ポナチニブ薬のグローバル市場展望 2023年-2029年：45mg、15mg
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC16504 )"オピオイド誘発性便秘（OLC）用治療薬のグローバル市場展望 2023年-2029年：市販薬、処方薬" (英文：Opioid Induced Constipation (OlC) Drugs Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。